Key result
Renal artery stenting linked to ~26 mm Hg lower systolic blood pressure at 6 months.
Why the study?
Preliminary experience suggested renal artery stenting improved results over balloon angioplasty alone in atherosclerotic renal artery stenosis, motivating this assessment of safety and efficacy in lesions difficult to treat with balloon angioplasty.
Does balloon-expandable renal artery stent placement improve angiographic success and blood pressure control in patients with poorly controlled hypertension and renal artery stenoses difficult to treat with balloon angioplasty alone?
Observational (n=100)
Does balloon-expandable renal artery stent placement improve angiographic success and blood pressure control in patients with poorly controlled hypertension and renal artery stenoses difficult to treat with balloon angioplasty alone?
Renal artery stent placement in lesions difficult to treat with balloon angioplasty achieves a 99% angiographic success rate, significantly lowers blood pressure and antihypertensive medication requirements at 6 months, and demonstrates a 19% restenosis rate at mean 8.7-month follow-up.
Answers are grounded in this paper and cite their sources.
May support stenting for angioplasty-refractory renal lesions; hypothesis-generating and requires randomized confirmation before practice change.
Objectives We assessed the safety and efficacy of stent placement in patients with poorly controlled hypertension and renal artery stenoses, which are difficult to treat with balloon angioplasty alone. Background Preliminary experience with stent placement suggests improved results over balloon angioplasty alone in patients with atherosclerotic renal artery stenosis. Methods Balloon-expandable stents were placed in 100 consecutive patients (133 renal arteries) with hypertension and renal artery stenosis. Sixty-seven of the patients had unilateral renal artery stenosis treated and 33 had bilateral renal artery stenoses treated with stents placed in both renal arteries. Results Angiographic success, as determined by quantitative angiography, was obtained in 132 (99%) of 133 lesions. Early clinical success was achieved in 76% of the patients. Six months after stent placement, the systolic blood pressure was reduced from 173 +/- 25 to 147 +/- 23 mm Hg (p < 0.001); the diastolic pressure from 88 +/- 17 to 76 +/- 12 mm Hg (p < 0.001); and the mean number of antihypertensive medications per patient from 2.6 +/- 1 to 2.0 +/- 0.9 (p < 0.001). Angiographic follow-up at a mean of 8.7 +/- 5.0 months in 67 patients revealed restenosis (>50% diameter narrowing) in 15 (19%) of 80 stented vessels. Conclusions Renal artery stenting is an effective treatment for renovascular hypertension, with a low angiographic restenosis rate. Stent placement appears to be a very attractive therapy in patients with lesions difficult to treat with balloon angioplasty such as renal aorto-ostial lesions and restenotic lesions, as well as after a suboptimal balloon angioplasty result.
No takes yet. Share an insight, caveat, or question.
White et al. (1997) conducted an observational in Poorly controlled hypertension and atherosclerotic renal artery stenosis (n=100). Balloon-expandable renal artery stent placement vs. Baseline (pre-stent placement) was evaluated on Angiographic success, early clinical success, and 6-month blood pressure reduction (p=<0.001). Renal artery stent placement achieved 99% angiographic success and reduced systolic blood pressure from 173 to 147 mm Hg at 6 months with 19% restenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: